Form 4: Perrigo Director Katherine Doyle Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Katherine Doyle reports acquisition and disposal of Perrigo Company plc ordinary shares and restricted stock units.

Summary

  • Katherine Doyle, a director of Perrigo Company plc, filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
  • On May 15, 2024, Doyle acquired 8,764 ordinary shares through the vesting of restricted stock units at a price of $30.22 per share.
  • On the same day, she disposed of 4,207 ordinary shares to cover tax obligations at a price of $30.22 per share.
  • Following these transactions, Doyle directly owns 14,963 ordinary shares.
  • She also holds 9,904 restricted stock units, vesting on May 14, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. There is no indication of unusual trading activity or concerns about the company's performance.

Positives

  • The acquisition of shares through vesting of restricted stock units indicates continued alignment of the director's interests with the company's performance.

Negatives

  • The disposal of shares to cover tax obligations, while common, slightly reduces the director's direct holdings.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

  • Monitoring insider transactions is a standard practice in corporate governance, with companies like Johnson & Johnson and Procter & Gamble also subject to similar reporting requirements.
  • The vesting of restricted stock units is a common form of executive compensation, aligning management's interests with shareholder value, similar to practices at Teva Pharmaceutical Industries and Mylan.

Stakeholder Impact

  • The transactions provide transparency to shareholders regarding insider trading activity.
  • The vesting of restricted stock units aligns the director's interests with those of shareholders.

Key Dates

DateDescription
2020-06-23Date of Power of Attorney execution.
2024-05-14Date of Restricted Stock Units grant.
2024-05-14Vesting date for 9,904 Restricted Stock Units.
2024-05-15Date of stock transactions (acquisition and disposal).
2024-05-15Vesting date for 8,764 Restricted Stock Units.
2024-05-16Date of Form 4 filing.
2025-05-14Vesting date for 9,904 Restricted Stock Units.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.